{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:57:28Z","timestamp":1788947848565,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11356-022-19979-1","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T21:02:51Z","timestamp":1649797371000},"page":"60035-60053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2"],"prefix":"10.1007","volume":"29","author":[{"given":"Khurshid","family":"Jalal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarrin","family":"Basharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Naseer","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reaz","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-6540","authenticated-orcid":false,"given":"Syed Shams ul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"19979_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"issue":"10","key":"19979_CR2","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1080\/07391102.2020.1770127","volume":"39","author":"K Abraham Peele","year":"2020","unstructured":"Abraham Peele K, Srihansa T, Krupanidhi S, Ayyagari VS, Venkateswarulu T, Dynamics (2020) Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. J Biomol Struct Dyn 39(10):3793\u20133801","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"19979_CR3","doi-asserted-by":"publisher","first-page":"e02147","DOI":"10.1128\/JVI.02147-16","volume":"91","author":"MA Angelo","year":"2017","unstructured":"Angelo MA, Grifoni A, O\u2019Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA (2017) Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity. J Virol 91(5):e02147-e12116","journal-title":"J Virol"},{"issue":"2","key":"19979_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/vaccines7020034","volume":"7","author":"SI Bazhan","year":"2019","unstructured":"Bazhan SI, Antonets DV, Karpenko LI, Oreshkova SF, Kaplina ON, Starostina EV, Dudko SG, Fedotova SA, Ilyichev AA (2019) In silico designed ebola virus T-cell multi-epitope DNA vaccine constructions are immunogenic in mice. Vaccines 7(2):34","journal-title":"Vaccines"},{"key":"19979_CR5","doi-asserted-by":"crossref","unstructured":"Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S (2022) CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 808:152072","DOI":"10.1016\/j.scitotenv.2021.152072"},{"issue":"1","key":"19979_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80899-6","volume":"11","author":"S Bibi","year":"2021","unstructured":"Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong W-B, Niu S (2021) In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep 11(1):1\u201316","journal-title":"Sci Rep"},{"issue":"15","key":"19979_CR7","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1128\/JVI.78.15.7867-7873.2004","volume":"78","author":"KW Boehme","year":"2004","unstructured":"Boehme KW, Compton T (2004) Innate sensing of viruses by toll-like receptors. J Virol 78(15):7867\u20137873","journal-title":"J Virol"},{"key":"19979_CR8","doi-asserted-by":"publisher","unstructured":"Brown KA, Gubbay J, Buchan SA, Daneman N, Mishra S, Patel S, Day T (2021) Inflection in prevalence of SARS-CoV-2 infections missing the N501Y mutation as a marker of rapid delta (B. 1.617. 2) lineage expansion in Ontario, Canada. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1122.21259349","DOI":"10.1101\/2021.1106.1122.21259349"},{"issue":"W1","key":"19979_CR9","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","volume":"47","author":"DW Buchan","year":"2019","unstructured":"Buchan DW, Jones DT (2019) The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Res 47(W1):W402\u2013W407","journal-title":"Nucleic Acids Res"},{"key":"19979_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/d41586-021-01696-3","volume":"595","author":"E Callaway","year":"2021","unstructured":"Callaway E (2021) Delta coronavirus variant: scientists brace for impact. Nature 595:17\u201318","journal-title":"Nature"},{"issue":"24","key":"19979_CR11","doi-asserted-by":"publisher","first-page":"2100509","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100509","volume":"26","author":"F Campbell","year":"2021","unstructured":"Campbell F, Archer B, Laurenson-Schafer H, Jinnai Y, Konings F, Batra N, Pavlin B, Vandemaele K, Van Kerkhove MD, Jombart T (2021) Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill 26(24):2100509","journal-title":"Euro Surveill"},{"key":"19979_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.antiviral.2017.01.023","volume":"140","author":"Y Cao","year":"2017","unstructured":"Cao Y, Li D, Fu Y, Bai Q, Chen Y, Bai X, Jing Z, Sun P, Bao H, Li P (2017) Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs. Antiviral Res 140:133\u2013141","journal-title":"Antiviral Res"},{"issue":"3","key":"19979_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2249.2010.04196.x","volume":"161","author":"M Carty","year":"2010","unstructured":"Carty M, Bowie AG (2010) Recent insights into the role of toll-like receptors in viral infection. Clin Exp Immunol 161(3):397\u2013406","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"19979_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39299-8","volume":"9","author":"V Chauhan","year":"2019","unstructured":"Chauhan V, Rungta T, Goyal K, Singh MP (2019) Designing a multi-epitope based vaccine to combat Kaposi sarcoma utilizing immunoinformatics approach. Sci Rep 9(1):1\u201315","journal-title":"Sci Rep"},{"issue":"11","key":"19979_CR15","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3201\/eid1511.090868","volume":"15","author":"H Chen","year":"2009","unstructured":"Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong MD, Farrar J, Riley S, Smith GJ (2009) Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerging Infect Dis 15(11):1849","journal-title":"Emerging Infect Dis"},{"issue":"1","key":"19979_CR16","first-page":"45","volume":"47","author":"P Chou","year":"1978","unstructured":"Chou P, Fasman G (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol 47(1):45\u2013148","journal-title":"Adv Enzymol"},{"key":"19979_CR17","unstructured":"Cowan R, Grosdidier G (2000) Visualization tools for monitoring and evaluation of distributed computing systems. Paper presented at the Proc. of the International Conference on Computing in High Energy and Nuclear Physics, Padova, Italy"},{"issue":"1","key":"19979_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6195-y","volume":"20","author":"A D\u2019Mello","year":"2019","unstructured":"D\u2019Mello A, Ahearn CP, Murphy TF, Tettelin H (2019) ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates. BMC Genom 20(1):1\u201321","journal-title":"BMC Genom"},{"key":"19979_CR19","doi-asserted-by":"publisher","unstructured":"Davis C, Logan N, Tyson G, Orton R, Harvey W, Haughney J, Perkins J, Peacock T, Barclay WS, Cherepanov P (2021) Reduced neutralisation of the delta (B. 1.617. 2) SARS-CoV-2 variant of concern following vaccination. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1123.21259327","DOI":"10.1101\/2021.1106.1123.21259327"},{"issue":"W1","key":"19979_CR20","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","volume":"47","author":"SK Dhanda","year":"2019","unstructured":"Dhanda SK, Mahajan S, Paul S, Yan Z, Kim H, Jespersen MC, Jurtz V, Andreatta M, Greenbaum JA, Marcatili P (2019) IEDB-AR: Immune epitope database\u2014analysis resource in 2019. Nucleic Acids Res 47(W1):W502\u2013W506","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"19979_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8(1):1\u20137","journal-title":"BMC Bioinform"},{"issue":"4","key":"19979_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y El-Manzalawy","year":"2008","unstructured":"El-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recognit 21(4):243\u2013255","journal-title":"J Mol Recognit"},{"issue":"3","key":"19979_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","volume":"55","author":"EA Emini","year":"1985","unstructured":"Emini EA, Hughes JV, Perlow D, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55(3):836\u2013839","journal-title":"J Virol"},{"key":"19979_CR24","doi-asserted-by":"publisher","unstructured":"Farinholt T, Doddapaneni H, Qin X, Menon V, Meng Q, Metcalf G, Chao H, Gingras M-C, Farinholt P, Agrawal C (2021) Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1128.21258780","DOI":"10.1101\/2021.1106.1128.21258780"},{"key":"19979_CR25","doi-asserted-by":"crossref","unstructured":"Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A (2020) Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comp Immunol Microbiol Infect Dis 69:101413","DOI":"10.1016\/j.cimid.2020.101413"},{"key":"19979_CR26","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. Proteomics Protocols Handbook 571\u2013607","DOI":"10.1385\/1-59259-890-0:571"},{"issue":"1","key":"19979_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/medicina57010055","volume":"57","author":"G Gheorghe","year":"2021","unstructured":"Gheorghe G, Ilie M, Bungau S, Stoian AMP, Bacalbasa N, Diaconu CC (2021) Is there a relationship between COVID-19 and hyponatremia? Medicina 57(1):55","journal-title":"Medicina"},{"key":"19979_CR28","doi-asserted-by":"crossref","unstructured":"Grote A, Hiller K, Scheer M, M\u00fcnch R, N\u00f6rtemann B, Hempel DC, Jahn D (2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33(suppl_2):W526\u2013W531","DOI":"10.1093\/nar\/gki376"},{"key":"19979_CR29","doi-asserted-by":"crossref","unstructured":"Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y (2014) Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model. Appl Microbiol Biotechnol 98(8):3495\u20133507","DOI":"10.1007\/s00253-013-5408-6"},{"issue":"9","key":"19979_CR30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/cmi.2017.3","volume":"15","author":"R He","year":"2018","unstructured":"He R, Yang X, Liu C, Chen X, Wang L, Xiao M, Ye J, Wu Y, Ye L (2018) Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model. Cell Mol Immunol 15(9):815\u2013826","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"19979_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/vim.2011.0099","volume":"25","author":"W Hu","year":"2012","unstructured":"Hu W, Yen Y-T, Singh S, Kao C-L, Wu-Hsieh BA (2012) SARS-CoV regulates immune function-related gene expression in human monocytic cells. Viral Immunol 25(4):277\u2013288","journal-title":"Viral Immunol"},{"issue":"12","key":"19979_CR32","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1021\/acs.jproteome.0c00717","volume":"19","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang C, Pearce R, Omenn GS, Zhang Y (2020) Identifying the zoonotic origin of SARS-CoV-2 by modeling the binding affinity between the spike receptor-binding domain and host ACE2. J Proteome Res 19(12):4844\u20134856","journal-title":"J Proteome Res"},{"issue":"27","key":"19979_CR33","doi-asserted-by":"publisher","first-page":"2100570","DOI":"10.2807\/1560-7917.ES.2021.26.27.2100570","volume":"26","author":"K Ito","year":"2021","unstructured":"Ito K, Piantham C, Nishiura H (2021) Predicted dominance of variant delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021. Euro Surveill 26(27):2100570","journal-title":"Euro Surveill"},{"issue":"1","key":"19979_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-03988-0","volume":"12","author":"K Jalal","year":"2022","unstructured":"Jalal K, Abu-Izneid T, Khan K, Abbas M, Hayat A, Bawazeer S, Uddin R (2022) Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach. Sci Rep 12(1):1\u201319","journal-title":"Sci Rep"},{"issue":"23","key":"19979_CR35","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","volume":"35","author":"P Jiang","year":"2017","unstructured":"Jiang P, Cai Y, Chen J, Ye X, Mao S, Zhu S, Xue X, Chen S, Zhang L (2017) Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model. Vaccine 35(23):3096\u20133103","journal-title":"Vaccine"},{"key":"19979_CR36","doi-asserted-by":"crossref","unstructured":"Kabir M, Uddin M, Hossain M, Abdulhakim JA, Alam M, Ashraf GM, Bungau SG, Bin-Jumah MN, Abdel-Daim MM, Aleya L (2020) nCOVID-19 pandemic: from molecular pathogenesis to potential investigational therapeutics. Front Cell Dev Biol 616","DOI":"10.3389\/fcell.2020.00616"},{"issue":"1","key":"19979_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-67749-1","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar T, Narsaria U, Basak S, Deb D, Castiglione F, Mueller DM, Srivastava AP (2020) A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep 10(1):1\u201324","journal-title":"Sci Rep"},{"issue":"4","key":"19979_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF01195768","volume":"72","author":"P Karplus","year":"1985","unstructured":"Karplus P, Schulz G (1985) Prediction of chain flexibility in proteins. Naturwissenschaften 72(4):212\u2013213","journal-title":"Naturwissenschaften"},{"key":"19979_CR39","doi-asserted-by":"crossref","unstructured":"Khan K, Jalal K, Uddin R (2022) An integrated in silico based subtractive genomics and reverse vaccinology approach for the identification of novel vaccine candidate and chimeric vaccine against XDR Salmonella typhi H58. Genomics 110301","DOI":"10.1016\/j.ygeno.2022.110301"},{"issue":"W1","key":"19979_CR40","doi-asserted-by":"publisher","first-page":"W525","DOI":"10.1093\/nar\/gks438","volume":"40","author":"Y Kim","year":"2012","unstructured":"Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, Lundegaard C, Sette A, Lund O, Bourne PE (2012) Immune epitope database analysis resource. Nucleic Acids Res 40(W1):W525\u2013W530","journal-title":"Nucleic Acids Res"},{"key":"19979_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1056\/NEJMsr2105280","volume":"385","author":"PR Krause","year":"2021","unstructured":"Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero A-M (2021) SARS-CoV-2 variants and vaccines. New Engl J Med 385:179\u2013186","journal-title":"New Engl J Med"},{"key":"19979_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2021.1106.1109.21258612","author":"A Kumar","year":"2021","unstructured":"Kumar A, Dwivedi P, Kumar G, Narayan RK, Jha RK, Parashar R, Sahni C, Pandey SN (2021a) Second wave of COVID-19 in India could be predicted with genomic surveillance of SARS-CoV-2 variants coupled with epidemiological data: a tool for future. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1109.21258612","journal-title":"medRxiv"},{"key":"19979_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27467","author":"A Kumar","year":"2021","unstructured":"Kumar A, Parashar R, Kumar S, Faiq MA, Kumari C, Kulandhasamy M, Narayan RK, Jha RK, Singh HN, Prasoon P (2021b) Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.27467","journal-title":"J Med Virol"},{"issue":"1","key":"19979_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinform 8(1):1\u201312","journal-title":"BMC Bioinform"},{"issue":"2","key":"19979_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"R Laskowski","year":"1993","unstructured":"Laskowski R, MacArthur M, Moss D, Thornton J (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26(2):283\u2013291","journal-title":"J Appl Crystallogr"},{"issue":"1","key":"19979_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM (2018) PDBsum: Structural summaries of PDB entries. Protein Sci 27(1):129\u2013134","journal-title":"Protein Sci"},{"issue":"7","key":"19979_CR47","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/v13071192","volume":"13","author":"I Lazarevic","year":"2021","unstructured":"Lazarevic I, Pravica V, Miljanovic D, Cupic M (2021) Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses 13(7):1192","journal-title":"Viruses"},{"key":"19979_CR48","doi-asserted-by":"crossref","unstructured":"Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, Von Boehmer L, Knuth A, Ochsenbein AF (2014) Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunol Immunother 63(4):381\u2013394","DOI":"10.1007\/s00262-013-1516-5"},{"key":"19979_CR49","doi-asserted-by":"crossref","unstructured":"Li J, Lai S, Gao GF, Shi W (2021) The emergence, genomic diversity and global spread of SARS-CoV-2. Nature 1\u201311","DOI":"10.1038\/s41586-021-04188-6"},{"issue":"W1","key":"19979_CR50","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco JR, Aliaga JI, Quintana-Ort\u00ed ES, Chac\u00f3n P (2014) iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res 42(W1):W271\u2013W276","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"19979_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/bjh.14686","volume":"178","author":"C Lu","year":"2017","unstructured":"Lu C, Meng S, Jin Y, Zhang W, Li Z, Wang F, Wang-Johanning F, Wei Y, Liu H, Tu H (2017) A novel multi-epitope vaccine from MMSA-1 and DKK 1 for multiple myeloma immunotherapy. Br J Haematol 178(3):413\u2013426","journal-title":"Br J Haematol"},{"key":"19979_CR52","doi-asserted-by":"crossref","unstructured":"Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M (2008) NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311. Nucleic Acids Res 36(suppl_2):W509\u2013W512","DOI":"10.1093\/nar\/gkn202"},{"issue":"17","key":"19979_CR53","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan CN, Randall A, Baldi P (2009) SOLpro: Accurate sequence-based prediction of protein solubility. Bioinformatics 25(17):2200\u20132207","journal-title":"Bioinformatics"},{"issue":"23","key":"19979_CR54","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan CN, Zeller M, Kayala MA, Vigil A, Randall A, Felgner PL, Baldi P (2010) High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics 26(23):2936\u20132943","journal-title":"Bioinformatics"},{"key":"19979_CR55","doi-asserted-by":"crossref","unstructured":"Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ (2008) FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res 36(suppl_2):W229\u2013W232","DOI":"10.1093\/nar\/gkn186"},{"key":"19979_CR56","doi-asserted-by":"publisher","unstructured":"Mlcochova P, Kemp SA, Shanker Dhar M, Papa G, Meng B, Mishra S, Whittaker C, Mellan T, Ferreira I, Datir R, Collier D, Singh S, Pandey R, Ponnusamy K, Radhakrishnan VS, Sengupta S, Brown J, Marwal R, Ponnusamy K, Radhakrishnan VS, Goonawardne N, Abdullahi A, Devi P, Wattal C, Caputo D, Peacock T, Goel N, Vaishya R, Charles O, Chattopadhyay P, Agarwal M, Satwik A, Consortium I, Collaboration NB, Mavousian A, Brown J, Zhou J, Goonawardne N, Hyeon Lee J, Bassi J, Silacci-Fegni C, Saliba C, Pinto D, Irie T, Yoshida I, Hamilton WL, Sato K, James L, Corti D, Piccoli L, Bhatt S, Flaxman S, Barlcay W, Rakshit P, Agrawal A, Gupta RK (2021) SARS-CoV-2 B. 1.617. 2 Delta variant emergence and vaccine breakthrough. bioRxiv. https:\/\/doi.org\/10.1101\/2021.1105.1108.443253","DOI":"10.1101\/2021.1105.1108.443253"},{"issue":"6","key":"19979_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10080","volume":"21","author":"N Negrut","year":"2021","unstructured":"Negrut N, Codrean A, Hodisan I, Bungau S, Tit DM, Marin R, Behl T, Banica F, Diaconu CC, Nistor-Cseppento DC (2021) Efficiency of antiviral treatment in COVID-19. Exp Therapeutic Med 21(6):1\u20137","journal-title":"Exp Therapeutic Med"},{"issue":"5","key":"19979_CR58","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen M, Lundegaard C, Worning P, Lauem\u00f8ller SL, Lamberth K, Buus S, Brunak S, Lund O (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12(5):1007\u20131017","journal-title":"Protein Sci"},{"key":"19979_CR59","doi-asserted-by":"crossref","unstructured":"Nosrati M, Behbahani M, Mohabatkar H (2019) Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: a computer-aided vaccine design approach. J Biomed Inf 93:103160","DOI":"10.1016\/j.jbi.2019.103160"},{"key":"19979_CR60","doi-asserted-by":"crossref","unstructured":"Ojha R, Gupta N, Naik B, Singh S, Verma VK, Prusty D, Prajapati VK (2020) High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19. Eur J Pharm Sci 151:105375","DOI":"10.1016\/j.ejps.2020.105375"},{"key":"19979_CR61","unstructured":"Papenfuss M (Jun. 25, 2021) Dangerous delta COVID-19 variant infecting vaccinated adults in Israel. Retrieved from https:\/\/www.huffpost.com\/entry\/covid-19-delta-infecting-vaccinated-in-israel_n_60d6661ce4b066ff5aba8faa"},{"issue":"19","key":"19979_CR62","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/bi00367a013","volume":"25","author":"J Parker","year":"1986","unstructured":"Parker J, Guo D, Hodges R (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25(19):5425\u20135432","journal-title":"Biochemistry"},{"issue":"13","key":"19979_CR63","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"2","key":"19979_CR64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.molimm.2015.05.008","volume":"66","author":"V Phongsisay","year":"2015","unstructured":"Phongsisay V, Iizasa EI, Hara H, Yoshida H (2015) Evidence for TLR4 and FcR\u03b3\u2013CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. Mol Immunol 66(2):463\u2013471","journal-title":"Mol Immunol"},{"key":"19979_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-41021-03777-41589","author":"D Planas","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J (2021) Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization. Nature. https:\/\/doi.org\/10.1038\/s41586-41021-03777-41589","journal-title":"Nature"},{"issue":"1","key":"19979_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui H-H, Li W, Fusseder N, Bourne PE, Sette A, Peters B (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform 9(1):1\u20138","journal-title":"BMC Bioinform"},{"key":"19979_CR67","doi-asserted-by":"crossref","unstructured":"Poudel S, Ishak A, Perez-Fernandez J, Garcia E, Le\u00f3n-Figueroa DA, Roman\u00ed L, Bonilla-Aldana DK, Rodriguez-Morales AJ (2022) Highly mutated SARS-CoV-2 omicron variant sparks significant concern among global experts\u2013what is known so far? Travel Med Infect Dis 45:102234","DOI":"10.1016\/j.tmaid.2021.102234"},{"issue":"5","key":"19979_CR68","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/v13050930","volume":"13","author":"E Quinonez","year":"2021","unstructured":"Quinonez E, Vahed M, Hashemi Shahraki A, Mirsaeidi M (2021) Structural analysis of the novel variants of SARS-CoV-2 and forecasting in North America. Viruses 13(5):930","journal-title":"Viruses"},{"issue":"3","key":"19979_CR69","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/vaccines8030423","volume":"8","author":"N Rahman","year":"2020","unstructured":"Rahman N, Ali F, Basharat Z, Shehroz M, Khan MK, Jeandet P, Nepovimova E, Kuca K, Khan H (2020) Vaccine design from the ensemble of surface glycoprotein epitopes of SARS-CoV-2: an immunoinformatics approach. Vaccines 8(3):423","journal-title":"Vaccines"},{"key":"19979_CR70","doi-asserted-by":"crossref","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F (2010) Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 5(4):e9862","DOI":"10.1371\/journal.pone.0009862"},{"key":"19979_CR71","doi-asserted-by":"crossref","unstructured":"Rappuoli R, Bottomley MJ, D\u2019Oro U, Finco O, De Gregorio E (2016) Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med 213(4):469\u2013481","DOI":"10.1084\/jem.20151960"},{"key":"19979_CR72","doi-asserted-by":"publisher","unstructured":"Riley S, Walters CE, Wang H, Eales O, Haw D, Ainslie KE, Atchinson C, Fronterre C, Diggle PJ, Page AJ (2021) REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the delta variant. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1117.21259103","DOI":"10.1101\/2021.1106.1117.21259103"},{"key":"19979_CR73","doi-asserted-by":"crossref","unstructured":"Saha S, Raghava GP (2007) Prediction methods for B-cell epitopes. Immunoinformatics 387\u2013394","DOI":"10.1007\/978-1-60327-118-9_29"},{"key":"19979_CR74","doi-asserted-by":"publisher","unstructured":"Salvatore M, Bhattacharyya R, Purkayastha S, Zimmermann L, Ray D, Hazra A, Kleinsasser M, Mellan TA, Whittaker C, Flaxman S (2021) Resurgence of SARS-CoV-2 in India: Potential role of the B. 1.617. 2 (delta) variant and delayed interventions. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1123.21259405","DOI":"10.1101\/2021.1106.1123.21259405"},{"key":"19979_CR75","doi-asserted-by":"crossref","unstructured":"Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Res 33(suppl_2):W363\u2013W367","DOI":"10.1093\/nar\/gki481"},{"issue":"4","key":"19979_CR76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","volume":"15","author":"A Sette","year":"2003","unstructured":"Sette A, Fikes J (2003) Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 15(4):461\u2013470","journal-title":"Curr Opin Immunol"},{"key":"19979_CR77","doi-asserted-by":"crossref","unstructured":"Sharma N, Patiyal S, Dhall A, Pande A, Arora C, Raghava GP (2020) AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes. Brief Bioinform 22(4):bbaa294","DOI":"10.1093\/bib\/bbaa294"},{"issue":"1","key":"19979_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"R Sharma","year":"2021","unstructured":"Sharma R, Rajput VS, Jamal S, Grover A, Grover S (2021) An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Sci Rep 11(1):1\u201312","journal-title":"Sci Rep"},{"issue":"10293","key":"19979_CR79","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","volume":"397","author":"A Sheikh","year":"2021","unstructured":"Sheikh A, McMenamin J, Taylor B, Robertson C (2021) SARS-CoV-2 Delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet 397(10293):2461\u20132462","journal-title":"Lancet"},{"issue":"1","key":"19979_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40833-x","volume":"9","author":"RA Shey","year":"2019","unstructured":"Shey RA, Ghogomu SM, Esoh KK, Nebangwa ND, Shintouo CM, Nongley NF, Asa BF, Ngale FN, Vanhamme L, Souopgui J (2019) In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci Rep 9(1):1\u201318","journal-title":"Sci Rep"},{"issue":"13","key":"19979_CR81","doi-asserted-by":"publisher","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","volume":"22","author":"Y Shu","year":"2017","unstructured":"Shu Y, McCauley J (2017) GISAID: Global initiative on sharing all influenza data\u2013from vision to reality. Euro Surveill 22(13):30494","journal-title":"Euro Surveill"},{"issue":"1","key":"19979_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4(1):1\u201314","journal-title":"Immunome Res"},{"issue":"15","key":"19979_CR83","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1158\/1078-0432.CCR-13-0002","volume":"19","author":"CL Slingluff","year":"2013","unstructured":"Slingluff CL, Lee S, Zhao F, Chianese-Bullock KA, Olson WC, Butterfield LH, Whiteside TL, Leming PD, Kirkwood JM (2013) A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602). Clin Cancer Res 19(15):4228\u20134238","journal-title":"Clin Cancer Res"},{"issue":"2","key":"19979_CR84","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10989-021-10159-2","volume":"27","author":"V Solanki","year":"2021","unstructured":"Solanki V, Sharma S, Tiwari V (2021) Subtractive proteomics and reverse vaccinology strategies for designing a multiepitope vaccine targeting membrane proteins of Klebsiella pneumoniae. Int J Pept Res Ther 27(2):1177\u20131195","journal-title":"Int J Pept Res Ther"},{"issue":"1","key":"19979_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26689-7","volume":"8","author":"V Solanki","year":"2018","unstructured":"Solanki V, Tiwari V (2018) Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Sci Rep 8(1):1\u201319","journal-title":"Sci Rep"},{"issue":"16","key":"19979_CR86","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1080\/07391102.2018.1548977","volume":"37","author":"S Srivastava","year":"2019","unstructured":"Srivastava S, Kamthania M, Kumar Pandey R, Kumar Saxena A, Saxena V, Kumar Singh S, Kumar Sharma R, Sharma N (2019) Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics. J Biomol Struct Dyn 37(16):4345\u20134360","journal-title":"J Biomol Struct Dyn"},{"key":"19979_CR87","doi-asserted-by":"crossref","unstructured":"Tagde P, Tagde S, Tagde P, Bhattacharya T, Monzur SM, Rahman M, Otrisal P, Behl T, Abdel-Daim MM, Aleya LJB (2021) Nutraceuticals and herbs in reducing the risk and improving the treatment of COVID-19 by targeting SARS-CoV-2. 9(9):1266","DOI":"10.3390\/biomedicines9091266"},{"issue":"12","key":"19979_CR88","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","volume":"22","author":"K Tao","year":"2021","unstructured":"Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, Fera D, Shafer RW (2021) The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet 22(12):757\u2013773","journal-title":"Nat Rev Genet"},{"key":"19979_CR89","doi-asserted-by":"crossref","unstructured":"Thakur V, Bhola S, Thakur P, Patel SKS, Kulshrestha S, Ratho RK, Kumar P (2021) Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe. Infection 1\u201316","DOI":"10.1007\/s15010-021-01734-2"},{"issue":"9","key":"19979_CR90","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00251-013-0714-9","volume":"65","author":"M Thomsen","year":"2013","unstructured":"Thomsen M, Lundegaard C, Buus S, Lund O, Nielsen M (2013) MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics 65(9):655\u2013665","journal-title":"Immunogenetics"},{"issue":"30","key":"19979_CR91","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1016\/S0264-410X(01)00111-6","volume":"19","author":"H Toledo","year":"2001","unstructured":"Toledo H, Baly A, Castro O, Resik S, Lafert\u00e9 J, Rolo F, Navea L, Lobaina L, Cruz O, Miguez J (2001) A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine 19(30):4328\u20134336","journal-title":"Vaccine"},{"issue":"1","key":"19979_CR92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07391102.2019.1707120","volume":"39","author":"SFDO Tosta","year":"2021","unstructured":"Tosta SFDO, Passos MS, Kato R, Salgado \u00c1, Xavier J, Jaiswal AK, Soares SC, Azevedo V, Giovanetti M, Tiwari S (2021) Multi-epitope based vaccine against yellow fever virus applying immunoinformatics approaches. J Biomol Struct Dyn 39(1):219\u2013235","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"19979_CR93","doi-asserted-by":"publisher","first-page":"e00638","DOI":"10.1128\/mBio.00638-15","volume":"6","author":"AL Totura","year":"2015","unstructured":"Totura AL, Whitmore A, Agnihothram S, Sch\u00e4fer A, Katze MG, Heise MT, Baric RS (2015) Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. Mbio 6(3):e00638-e1615","journal-title":"Mbio"},{"key":"19979_CR94","doi-asserted-by":"crossref","unstructured":"Uddin R, Jalal K, Khan K (2022) Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors. J Mol Struct 1250:131920","DOI":"10.1016\/j.molstruc.2021.131920"},{"key":"19979_CR95","doi-asserted-by":"crossref","unstructured":"Ullah MA, Sarkar B, Islam SS (2020) Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus. Immunobiology 225(3):151949","DOI":"10.1016\/j.imbio.2020.151949"},{"key":"19979_CR96","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","volume":"5","author":"C Vaure","year":"2014","unstructured":"Vaure C, Liu Y (2014) A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 5:316","journal-title":"Front Immunol"},{"issue":"10296","key":"19979_CR97","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(21)01462-8","volume":"398","author":"EC Wall","year":"2021","unstructured":"Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E (2021) AZD1222-induced neutralising antibody activity against SARS-CoV-2 delta VOC. The Lancet 398(10296):207\u2013209","journal-title":"The Lancet"},{"key":"19979_CR98","doi-asserted-by":"crossref","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(suppl_2):W407\u2013W410","DOI":"10.1093\/nar\/gkm290"},{"key":"19979_CR99","unstructured":"World Health Organization: Interim recommendations for use of the Pfizer\u2013BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing: interim guidance, first issued 8 January 2021, updated 15 June 2021. (2021). Retrieved from Geneva: WHO reference number: WHO\/2019-nCoV\/vaccines\/SAGE_recommendation\/\/BNT162b2\/2021.2"},{"key":"19979_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874285800802010049","volume":"2","author":"A Xagorari","year":"2008","unstructured":"Xagorari A, Chlichlia K (2008) Toll-like receptors and viruses: Induction of innate antiviral immune responses. Open Microbiol J 2:49","journal-title":"Open Microbiol J"},{"key":"19979_CR101","doi-asserted-by":"publisher","unstructured":"Yang W, Shaman J (2021) COVID-19 pandemic dynamics in India and impact of the SARS-CoV-2 Delta (B. 1.617. 2) variant. medRxiv. https:\/\/doi.org\/10.1101\/2021.1106.1121.21259268","DOI":"10.1101\/2021.1106.1121.21259268"},{"issue":"1","key":"19979_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang Z, Bogdan P, Nazarian S (2021) An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep 11(1):1\u201321","journal-title":"Sci Rep"},{"issue":"2","key":"19979_CR103","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L (2018) Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol 15(2):182\u2013184","journal-title":"Cell Mol Immunol"},{"issue":"36","key":"19979_CR104","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","volume":"27","author":"W-Y Zhou","year":"2009","unstructured":"Zhou W-Y, Shi Y, Wu C, Zhang W-J, Mao X-H, Guo G, Li H-X, Zou Q-M (2009) Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model. Vaccine 27(36):5013\u20135019","journal-title":"Vaccine"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-19979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-022-19979-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-19979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:11:44Z","timestamp":1668298304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-022-19979-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":104,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["19979"],"URL":"https:\/\/doi.org\/10.1007\/s11356-022-19979-1","relation":{},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors have approved the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}